Pembrolizumab (pembro) plus chemotherapy (chemo) for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Updated results from the KEYNOTE-859 study

Autores de IDIVAL

• 

  Fernando Rivera Herrero

  Autor

Autores ajenos al IDIVAL

• Rha, SY
• Wyrwicz, LS
• Weber, PEY
• Bai, YX
• Ryu, MH
• Lee, J
• Alves, GV
• Garrido, M
• Shiu, KK
• Fernández, MG
• Li, J
• Lowery, MA
• Cil, T
• Cruz, FM
• Oh, DY
• Yin, LN
• Bordia, S
• Bhagia, P
• Qin, SK

Unidades

• ONCOLOGÍA MÉDICA

  

  Investigador Responsable

  Fernando Rivera Herrero

Abstract

Abstract no disponible